Table 2.

MPA levels at the end of the injection interval (week 12) by study arm.

	N	Mean (95% CL)	% < 0.2 ng/ml	% < 0.1 ng/ml	% < 0.02 ng/ml
Interval 1
Placebo	35	0.49 (0.40, 1.27)	28.6	20.0	5.7
TDF/FTC	26	0.37 (0.25, 1.99)	46.2	34.6	15.4
Pooled	61	0.44 (0.39, 1.14)	36.1	26.2	9.8
Interval 2
Placebo	30	0.39 (0.31, 1.17)	30.0	23.3	6.7
TDF/FTC	19	0.28 (0.19, 1.22)	47.4	31.6	10.5
Pooled	49	0.35 (0.30, 0.84)	36.7	26.5	8.2